Alluvi tirzepatide appears to have emerged as a promising therapeutic option for the management of metabolic disorders. This exploratory evaluation explored the efficacy and profile of tirzepatide 40mg in experimental models of type 2 diabetes. The research demonstrated that tirzepatide 40mg markedly improved glycemic regulation and reduced insulin